This is what one Hedge Fund manager said about Ampio
I won't waste time commenting on the rest of the article, but can say the comments about only one hedge fund being long AMPE is BS. I've run a hedge fund for the last decade and my fund is long AMPE. I also know a couple other funds that have gotten long AMPE. The summary of our assessments on the three drugs are:
Zertane: Hard to say how big the market will ultimately be, but getting a partner for this and having the drug be profitable seems likely.
Ampio: will be a multi billion dollar drug if approved and the available data looks very promising.
Optina: Has longer to go on the trial map, but available data looks very good and the drug would be a layup multi billion dollar drug if approved.